{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T01:08:11Z","timestamp":1793149691367,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T00:00:00Z","timestamp":1651881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T00:00:00Z","timestamp":1651881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Thrombotic microangiopathy-induced\n                      <jats:italic>thrombocytopenia-associated multiple organ failure<\/jats:italic>\n                      and hyperinflammatory\n                      <jats:italic>macrophage activation syndrome<\/jats:italic>\n                      are important causes of late pediatric sepsis mortality that are often missed or have delayed diagnosis. The National Institutes of General Medical Science sepsis research working group recommendations call for application of new research approaches in extant clinical data sets to improve efficiency of early trials of new sepsis therapies. Our objective is to apply machine learning approaches to derive computable 24-h sepsis phenotypes to facilitate personalized enrollment in early anti-inflammatory trials targeting these conditions.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We applied consensus,\n                      <jats:italic>k<\/jats:italic>\n                      -means clustering analysis to our extant PHENOtyping sepsis-induced Multiple organ failure Study (PHENOMS) dataset of 404 children. 24-hour computable phenotypes are derived using 25 available bedside variables including C-reactive protein and ferritin.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Four computable phenotypes (PedSep-A, B, C, and D) are derived. Compared to all other phenotypes, PedSep-A patients (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009135; 2% mortality) were younger and previously healthy, with the lowest C-reactive protein and ferritin levels, the highest lymphocyte and platelet counts, highest heart rate, and lowest creatinine (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05); PedSep-B patients (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009102; 12% mortality) were most likely to be intubated and had the lowest Glasgow Coma Scale Score (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05); PedSep-C patients (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009110; mortality 10%) had the highest temperature and Glasgow Coma Scale Score, least pulmonary failure, and lowest lymphocyte counts (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05); and PedSep-D patients (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200956, 34% mortality) had the highest creatinine and number of organ failures, including renal, hepatic, and hematologic organ failure, with the lowest platelet counts (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). PedSep-D had the highest likelihood of developing\n                      <jats:italic>thrombocytopenia-associated multiple organ failure<\/jats:italic>\n                      (Adj OR 47.51 95% CI [18.83\u2013136.83],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001) and\n                      <jats:italic>macrophage activation syndrome<\/jats:italic>\n                      (Adj OR 38.63 95% CI [13.26\u2013137.75],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Four computable phenotypes are derived, with PedSep-D being optimal for enrollment in early personalized anti-inflammatory trials targeting thrombocytopenia-associated multiple organ failure and macrophage activation syndrome in pediatric sepsis. A computer tool for identification of individual patient membership (\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.pedsepsis.pitt.edu\">www.pedsepsis.pitt.edu<\/jats:ext-link>\n                      ) is provided. Reproducibility will be assessed at completion of two ongoing pediatric sepsis studies.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13054-022-03977-3","type":"journal-article","created":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T07:21:02Z","timestamp":1651908062000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Machine learning derivation of four computable 24-h pediatric sepsis phenotypes to facilitate enrollment in early personalized anti-inflammatory clinical trials"],"prefix":"10.1186","volume":"26","author":[{"given":"Yidi","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate F.","family":"Kernan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenjiang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Jung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soyeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott W.","family":"Canna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Kellum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wessel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murray M.","family":"Pollack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Meert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Newth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Doctor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Shanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Cornell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rick E.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athena F.","family":"Zuppa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Banks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron W.","family":"Reeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Holubkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Notterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Michael Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Carcillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,7]]},"reference":[{"key":"3977_CR1","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study. Lancet. 2020;395:200\u201311.","journal-title":"Lancet"},{"key":"3977_CR2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/PCC.0000000000000978","volume":"18","author":"JC Lin","year":"2017","unstructured":"Lin JC, Spinella PC, Fitzgerald JC, et al. Sepsis Prevalence, Outcomes, and Therapy Study Investigators. New or progressive multiple organ dysfunction syndrome in pediatric severe sepsis: a sepsis phenotype with higher morbidity and mortality. Pediatr Crit Care Med. 2017;18:8\u201316.","journal-title":"Pediatr Crit Care Med"},{"key":"3977_CR3","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1164\/rccm.201412-2323OC","volume":"191","author":"SL Weiss","year":"2015","unstructured":"Weiss SL, Fitzgerald JC, Pappachan J, et al. Sepsis Prevalence, Outcomes, and Therapies (SPROUT) Study Investigators and Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network. Global epidemiology of pediatric severe sepsis: the sepsis prevalence, outcomes, and therapies study. Am J Respir Crit Care Med. 2015;191:1147\u201357.","journal-title":"Am J Respir Crit Care Med"},{"key":"3977_CR4","doi-asserted-by":"publisher","first-page":"e451","DOI":"10.1097\/PCC.0000000000000906","volume":"17","author":"JK Workman","year":"2016","unstructured":"Workman JK, Ames SG, Reeder RW, et al. Treatment of pediatric septic shock with the surviving sepsis campaign guidelines and PICU patient outcomes. Pediatr Crit Care Med. 2016;17:e451\u20138.","journal-title":"Pediatr Crit Care Med"},{"key":"3977_CR5","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1001\/jama.2018.9071","volume":"320","author":"IVR Evans","year":"2018","unstructured":"Evans IVR, Phillips GS, Alpern ER, et al. Association between the New York Sepsis Care mandate and in-hospital mortality for pediatric sepsis. JAMA. 2018;320:358\u201367.","journal-title":"JAMA"},{"issue":"1","key":"3977_CR6","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s13054-018-2147-1","volume":"22","author":"SG Ames","year":"2018","unstructured":"Ames SG, Horvat CM, Zaritsky A, Carcillo JA. The path to great pediatric septic shock outcomes. Crit Care. 2018;22(1):224.","journal-title":"Crit Care"},{"key":"3977_CR7","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1164\/rccm.201710-2006OC","volume":"198","author":"JA Muszynski","year":"2018","unstructured":"Muszynski JA, Nofziger R, Moore-Clingenpeel M, et al. Early immune function and duration of organ dysfunction in critically III children with sepsis. Am J Respir Crit Care Med. 2018;198:361\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"3977_CR8","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00134-010-2088-x","volume":"37","author":"MW Hall","year":"2011","unstructured":"Hall MW, Knatz NL, Vetterly C, et al. Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome. Intensive Care Med. 2011;37:525\u201332.","journal-title":"Intensive Care Med"},{"key":"3977_CR9","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1097\/CCM.0b013e318186aa49","volume":"36","author":"TC Nguyen","year":"2008","unstructured":"Nguyen TC, Han YY, Kiss JE, et al. Intensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failure. Crit Care Med. 2008;36:2878\u201387.","journal-title":"Crit Care Med"},{"key":"3977_CR10","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1097\/CCM.0000000000001852","volume":"44","author":"HR Wong","year":"2016","unstructured":"Wong HR, Cvijanovich NZ, Anas N, et al. Pediatric sepsis biomarker risk model-II: redefining the pediatric sepsis biomarker risk model with septic shock phenotype. Crit Care Med. 2016;44:2010\u20137.","journal-title":"Crit Care Med"},{"key":"3977_CR11","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1203\/00006450-200212000-00018","volume":"52","author":"L Doughty","year":"2002","unstructured":"Doughty L, Clark RS, Kaplan SS, Sasser H, Carcillo J. sFas and sFas ligand and pediatric sepsis-induced multiple organ failure syndrome. Pediatr Res. 2002;52:922\u20137.","journal-title":"Pediatr Res"},{"key":"3977_CR12","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12916-017-0930-5","volume":"15","author":"E Kyriazopoulou","year":"2017","unstructured":"Kyriazopoulou E, Leventogiannis K, Norrby-Teglund A, et al. Hellenic Sepsis Study Group Macrophage activation-like syndrome: an immunological entity associated with rapid progression to death in sepsis. BMC Med. 2017;15:172.","journal-title":"BMC Med"},{"key":"3977_CR13","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/CCM.0000000000001402","volume":"44","author":"B Shakoory","year":"2016","unstructured":"Shakoory B, Carcillo JA, Chatham WW, et al. Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III trial. Crit Care Med. 2016;44:275\u201381.","journal-title":"Crit Care Med"},{"key":"3977_CR14","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1097\/PCC.0000000000001052","volume":"18","author":"JA Carcillo","year":"2017","unstructured":"Carcillo JA, Podd B, Aneja R, et al. Pathophysiology of pediatric multiple organ dysfunction syndrome. Pediatr Crit Care Med. 2017;18:S32\u201345.","journal-title":"Pediatr Crit Care Med"},{"key":"3977_CR15","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/PCC.0000000000002105","volume":"20","author":"JA Carcillo","year":"2019","unstructured":"Carcillo JA, Berg RA, Wessel D, et al. A multicenter network assessment of three inflammation phenotypes in pediatric sepsis-induced multiple organ failure. Pediatr Crit Care Med. 2019;20:1137\u201346.","journal-title":"Pediatr Crit Care Med"},{"key":"3977_CR16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/ajh.1141","volume":"68","author":"U Emmenegger","year":"2001","unstructured":"Emmenegger U, Frey U, Reimers A, et al. Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromes. Am J Hematol. 2001;68:4\u201310.","journal-title":"Am J Hematol"},{"key":"3977_CR17","doi-asserted-by":"publisher","first-page":"R52","DOI":"10.1186\/cc11256","volume":"16","author":"D Demirkol","year":"2012","unstructured":"Demirkol D, Yildizdas D, Bayrakci B, et al. Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis\/sepsis\/multiple organ dysfunction syndrome\/macrophage activation syndrome: what is the treatment? Crit Care. 2012;16:R52.","journal-title":"Crit Care"},{"key":"3977_CR18","doi-asserted-by":"publisher","first-page":"e354","DOI":"10.1097\/PCC.0000000000000227","volume":"15","author":"E Sevketoglu","year":"2014","unstructured":"Sevketoglu E, Yildizdas D, Horoz OO, et al. Use of therapeutic plasma exchange in children with thrombocytopenia-associated multiple organ failure in the Turkish thrombocytopenia-associated multiple organ failure network. Pediatr Crit Care Med. 2014;15:e354-359.","journal-title":"Pediatr Crit Care Med"},{"key":"3977_CR19","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1097\/CCM.0000000000003559","volume":"47","author":"JD Fortenberry","year":"2019","unstructured":"Fortenberry JD, Nguyen T, Grunwell JR, et al. Therapeutic plasma exchange in children with thrombocytopenia-associated multiple organ failure: the thrombocytopenia-associated multiple organ failure network prospective experience. Thrombocytopenia-associated multiple organ failure (TAMOF) network study group. Crit Care Med. 2019;47:e173\u201381.","journal-title":"Crit Care Med"},{"key":"3977_CR20","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1001\/jama.2019.5791","volume":"321","author":"CW Seymour","year":"2019","unstructured":"Seymour CW, Kennedy JN, Wang S, et al. Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis. JAMA. 2019;321:2003\u201317.","journal-title":"JAMA"},{"key":"3977_CR21","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1542\/pir.2018-0101","volume":"41","author":"MD Taylor","year":"2020","unstructured":"Taylor MD, Allada V, Moritz ML, et al. Use of C-reactive protein and ferritin biomarkers in daily pediatric practice. Pediatr Rev. 2020;41:172\u201383.","journal-title":"Pediatr Rev"},{"key":"3977_CR22","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1177\/0009922819837352","volume":"58","author":"CM Horvat","year":"2019","unstructured":"Horvat CM, Bell J, Kantawala S, et al. C-reactive protein and ferritin are associated with organ dysfunction and mortality in hospitalized children. Clin Pediatr. 2019;58:752\u201360.","journal-title":"Clin Pediatr"},{"key":"3977_CR23","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/01.PCC.0000149131.72248.E6","volume":"6","author":"B Goldstein","year":"2005","unstructured":"Goldstein B, Giroir B, Randolph A, International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005;6:2\u20138.","journal-title":"Pediatr Crit Care Med"},{"key":"3977_CR24","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13613-016-0144-6","volume":"6","author":"A Villeneuve","year":"2016","unstructured":"Villeneuve A, Joyal JS, Proulx F, et al. Multiple organ dysfunction syndrome in critically ill children: clinical value of two lists of diagnostic criteria. Ann Intens Care. 2016;6:40.","journal-title":"Ann Intens Care"},{"key":"3977_CR25","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1097\/CCM.0000000000004842","volume":"49","author":"KM DeMerle","year":"2021","unstructured":"DeMerle KM, Angus DC, Baillie JK, et al. Sepsis subclasses: a framework for development and interpretation. Crit Care Med. 2021;49:748\u201359.","journal-title":"Crit Care Med"},{"key":"3977_CR26","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson MD, Hayes DN. Consensus Cluster Plus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26:1572\u20133.","journal-title":"Bioinformatics"},{"key":"3977_CR27","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1097\/PCC.0000000000001122","volume":"18","author":"JA Carcillo","year":"2017","unstructured":"Carcillo JA, Halstead ES, Hall MW, et al. Three hypothetical inflammation pathobiology phenotypes and pediatric sepsis-induced multiple organ failure outcome. Pediatr Crit Care Med. 2017;18:513\u201323.","journal-title":"Pediatr Crit Care Med"},{"key":"3977_CR28","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1467-9868.2005.00503.x","volume":"67","author":"H Zou","year":"2005","unstructured":"Zou H, Hastie T. Regularization and variable selection via the Elastic Net. J R Stat Soc Ser B Stat Methodol. 2005;67:301\u201320.","journal-title":"J R Stat Soc Ser B Stat Methodol"},{"key":"3977_CR29","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1182\/blood-2017-12-820852","volume":"131","author":"ES Weiss","year":"2018","unstructured":"Weiss ES, Girard-Guyonvarc\u2019h C, Holzinger D, et al. Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome. Blood. 2018;131:1442\u201355.","journal-title":"Blood"},{"key":"3977_CR30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJMoa2102605","volume":"385","author":"MBF Son","year":"2021","unstructured":"Son MBF, Murray N, Friedman K, et al. Multisystem inflammatory syndrome in children\u2014initial therapy and outcomes. N Engl J Med. 2021;385:23\u201334.","journal-title":"N Engl J Med"},{"key":"3977_CR31","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S2213-2600(17)30294-1","volume":"5","author":"BP Scicluna","year":"2017","unstructured":"Scicluna BP, van Vught LA, Zwinderman AH, et al. Classification of patients with sepsis according to blood genomic endotype. Lancet Resp Med. 2017;5:816\u201326.","journal-title":"Lancet Resp Med"},{"key":"3977_CR32","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1097\/CCM.0000000000003084","volume":"46","author":"TE Sweeney","year":"2018","unstructured":"Sweeney TE, Azad TD, Donato M, et al. Unsupervised analysis of transcriptomics in bacterial sepsis across multiple datasets reveals three robust clusters. Crit Care Med. 2018;46:915\u201325.","journal-title":"Crit Care Med"},{"key":"3977_CR33","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S2213-2600(16)00046-1","volume":"4","author":"E Davenport","year":"2016","unstructured":"Davenport E, Burnham KL, Radhakrishnan J, et al. Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study. Lancet Respir Med. 2016;4:259\u201371.","journal-title":"Lancet Respir Med"},{"key":"3977_CR34","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/CCM.0000000000004122","volume":"48","author":"JJ Zimmerman","year":"2020","unstructured":"Zimmerman JJ, Banks R, Berg RA, et al. Life After Pediatric Sepsis Evaluation (LAPSE) Investigators. Critical illness factors associated with long-term mortality and health-related quality of life morbidity following community-acquired pediatric septic shock. Crit Care Med. 2020;48:319\u201328.","journal-title":"Crit Care Med"},{"key":"3977_CR35","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1007\/s00134-015-3764-7","volume":"41","author":"DB Knox","year":"2015","unstructured":"Knox DB, Lanspa MJ, Kuttler KG, Brewer SC, Brown SM. Phenotypic clusters within sepsis-associated multiple organ dysfunction syndrome. Intensive Care Med. 2015;41:814\u201322.","journal-title":"Intensive Care Med"},{"key":"3977_CR36","first-page":"1345","volume":"2020","author":"J Ye","year":"2021","unstructured":"Ye J, Sanchez-Pinto LN. Three data-driven phenotypes of multiple organ dysfunction syndrome preserved from early childhood to middle adulthood. AMIA Annu Symp Proc. 2021;2020:1345\u201353.","journal-title":"AMIA Annu Symp Proc"},{"key":"3977_CR37","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3201\/eid2606.190783","volume":"26","author":"A Cook","year":"2020","unstructured":"Cook A, Janse S, Watson JR, et al. Manifestations of toxic shock syndrome in children, Columbus, Ohio, USA, 2010\u20132017. Emerg Infect Dis. 2020;26:1077\u201383.","journal-title":"Emerg Infect Dis"},{"key":"3977_CR38","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1177\/0009922817729483","volume":"57","author":"L Ma","year":"2018","unstructured":"Ma L, Zhang YY, Yu HG. Clinical manifestations of Kawasaki disease shock syndrome. Clin Pediatr. 2018;57:428\u201335.","journal-title":"Clin Pediatr"},{"key":"3977_CR39","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jpeds.2017.08.076","volume":"191","author":"T Ebato","year":"2017","unstructured":"Ebato T, Ogata S, Ogihara Y, et al. The clinical utility and safety of a new strategy for the treatment of refractory Kawasaki disease. J Pediatr. 2017;191:140\u20134.","journal-title":"J Pediatr"},{"issue":"11","key":"3977_CR40","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1038\/s41591-020-1054-6","volume":"26","author":"MJ Carter","year":"2020","unstructured":"Carter MJ, Fish M, Jennings A, et al. Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection. Nat Med. 2020;26(11):1701\u20137.","journal-title":"Nat Med"},{"key":"3977_CR41","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13578-020-00400-8","volume":"10","author":"SF Chang","year":"2020","unstructured":"Chang SF, Liu SF, Chen CN, et al. Serum IP-10 and IL-17 from Kawasaki disease patients induce calcification-related genes and proteins in human coronary artery smooth muscle cells in vitro. Cell Biosci. 2020;10:36.","journal-title":"Cell Biosci"},{"key":"3977_CR42","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.4049\/jimmunol.1601366","volume":"198","author":"PA Szabo","year":"2017","unstructured":"Szabo PA, Goswami A, Mazzuca DM, et al. Rapid and rigorous IL-17A production by a distinct subpopulation of effector memory T lymphocytes constitutes a novel mechanism of toxic shock syndrome immunopathology. J Immunol. 2017;198:2805\u201318.","journal-title":"J Immunol"},{"key":"3977_CR43","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S2213-2600(14)70097-9","volume":"2","author":"CS Calfee","year":"2014","unstructured":"Calfee CS, Delucchi K, Parsons PE, et al. Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomized controlled trials. Lance Resp Med. 2014;2:611\u201320.","journal-title":"Lance Resp Med"},{"key":"3977_CR44","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1164\/rccm.202002-0347OC","volume":"202","author":"P Sinha","year":"2020","unstructured":"Sinha P, Churpek MM, Calfee CS. Machine learning classifier models can identify ARDS phenotypes using readily available clinical data. Am J Respir Crit Care Med. 2020;202:996\u20131004.","journal-title":"Am J Respir Crit Care Med"},{"key":"3977_CR45","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1093\/rheumatology\/kez282","volume":"59","author":"S Yasin","year":"2020","unstructured":"Yasin S, Fall N, Brown RA, et al. IL-18 as a biomarker linking systemic juvenile idiopathic arthritis and macrophage activation syndrome. Rheumatology. 2020;59:361\u20136.","journal-title":"Rheumatology"},{"key":"3977_CR46","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jped.2020.07.008","volume":"97","author":"CT Tonial","year":"2021","unstructured":"Tonial CT, Costa CAD, Andrades GRH, et al. Performance of prognostic markers in pediatric sepsis. J Pediatr (Rio J). 2021;97:287\u201394.","journal-title":"J Pediatr (Rio J)"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-022-03977-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-022-03977-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-022-03977-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T00:40:52Z","timestamp":1700527252000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-022-03977-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,7]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3977"],"URL":"https:\/\/doi.org\/10.1186\/s13054-022-03977-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.12.02.21267016","asserted-by":"object"}]},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,7]]},"assertion":[{"value":"16 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board at University of Utah Central IRB # 70976.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interest but did have the following and sources of funding. Drs. Carcillo\u2019s, Berg\u2019s, Wessel\u2019s, Pollack\u2019s, Meert\u2019s, Hall\u2019s, Doctor\u2019s, Cornell\u2019s, Harrison\u2019s, Zuppa\u2019s, Reeder\u2019s, Banks\u2019s, and Holubkov\u2019s institutions received funding from the National Institutes of Health (NIH). Drs. Carcillo\u2019s, Newth\u2019s, Shanley\u2019s, and Dean\u2019s institutions received funding from the National Institutes of Child Health and Human Development. Drs. Carcillo, Berg, Wessel, Polack, Meert, Hall, Newth, Doctor, Shanley, Cornell, Harrison, Zuppa, Reeder, Banks, Holubkov, Notterman, and Dean received support for article research from the NIH. Dr. Carcillo\u2019s institution also received funding from the National Institutes of General Medical Sciences. Dr. Pollack disclosed that his research is supported by philanthropy from Mallinckrodt Pharmaceuticals. Dr. Hall received funding from Bristol Myers-Squibb (for service on an advisory board) and LaJolla Pharmaceuticals (service as a consultant), both unrelated to the current submission. Dr. Newth received funding from Philips Research North America. Dr. Doctor\u2019s institution received funding from the Department of Defense and Kalocyte. Dr. Shanley received funding from Springer publishing, International Pediatric Research Foundation, and Pediatric Academic Societies. Dr. Cornell disclosed he is co-founder of Pre-Dixon Bio. Dr. Holubkov received funding from Pfizer (Data Safety Monitoring Board [DSMB] member), Medimmune (DSMB member), Physicians Committee for Responsible Medicine (biostatistical consulting), DURECT Corporation (biostatistical consulting), Armaron Bio (DSMB past member), and St Jude Medical (DSMB past member). The remaining authors have disclosed that they do not have any potential competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"128"}}